SIONSionna Therapeutics, Inc.
- Market cap
- $162.76M
- as of 2026-10-23
- Latest close
- $3.60
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2025-02-10
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | Sep 17 | Sep 21 | S | 3,415,011 | $6.32 | Sale −$21,582,870 | 3,482,612 | No | Form 4 |
| Ra Capital Management, L.P. | Sep 17 | Sep 21 | S | 33,800 | $7.46 | Sale −$252,148 | 3,448,812 | No | Form 4 |
| Cloonan MichaelPresident & CEO | Sep 17 | Sep 18 | A | 109,025 | $0.00 | $0 | 656,368 | No | Form 4 |
| Cloonan MichaelPresident & CEO | Sep 17 | Sep 18 | A | 109,025 | $0.00 | $0 | 765,393 | No | Form 4 |
| Cloonan MichaelPresident & CEO | Sep 17 | Sep 18 | A · derivative | 436,100 | $7.18 | $3,131,198 | 436,100 | No | Form 4 |
| Cloonan MichaelPresident & CEO | Sep 17 | Sep 18 | D · derivative | 436,100 | $39.21 | $17,099,481 | not reported | No | Form 4 |
| Ridloff ElenaCFO and CBO | Sep 17 | Sep 18 | A | 47,269 | $0.00 | $0 | 85,801 | No | Form 4 |
| Ridloff ElenaCFO and CBO | Sep 17 | Sep 18 | A | 47,268 | $0.00 | $0 | 133,069 | No | Form 4 |
| Ridloff ElenaCFO and CBO | Sep 17 | Sep 18 | A · derivative | 165,440 | $7.18 | $1,187,859 | 165,440 | No | Form 4 |
| Ridloff ElenaCFO and CBO | Sep 17 | Sep 18 | D · derivative | 165,440 | $39.21 | $6,486,902 | not reported | No | Form 4 |
| McKee CharlotteCMO and Head of R&D | Sep 17 | Sep 18 | A | 50,000 | $0.00 | $0 | 78,415 | No | Form 4 |
| McKee CharlotteCMO and Head of R&D | Sep 17 | Sep 18 | A | 50,000 | $0.00 | $0 | 128,415 | No | Form 4 |
| McKee CharlotteCMO and Head of R&D | Sep 17 | Sep 18 | A · derivative | 155,700 | $7.18 | $1,117,926 | 155,700 | No | Form 4 |
| McKee CharlotteCMO and Head of R&D | Sep 17 | Sep 18 | D · derivative | 155,700 | $39.21 | $6,104,997 | not reported | No | Form 4 |
| Fitzpatrick JenniferCLO and Head of Program Mgmt. | Sep 17 | Sep 18 | A | 28,133 | $0.00 | $0 | 28,133 | No | Form 4 |
| Fitzpatrick JenniferCLO and Head of Program Mgmt. | Sep 17 | Sep 18 | A | 28,132 | $0.00 | $0 | 56,265 | No | Form 4 |
| Fitzpatrick JenniferCLO and Head of Program Mgmt. | Sep 17 | Sep 18 | A · derivative | 103,140 | $7.18 | $740,545 | 103,140 | No | Form 4 |
| Fitzpatrick JenniferCLO and Head of Program Mgmt. | Sep 17 | Sep 18 | D · derivative | 103,140 | $39.21 | $4,044,119 | not reported | No | Form 4 |
| OrbiMed Capital GP VIII LLC | Jul 7 | Jul 9 | S | 85,918 | $44.86 | Sale −$3,854,281 | 2,469,959 | Yes | Form 4 |
| Thompson Peter A. | Jul 7 | Jul 9 | S | 85,918 | $44.86 | Sale −$3,854,281 | 2,469,959 | Yes | Form 4 |
| Fitzpatrick JenniferChief Legal Officer | Jul 6 | Jul 7 | M | 10,250 | $6.11 | $62,628 | 10,250 | Yes | Form 4 |
| Fitzpatrick JenniferChief Legal Officer | Jul 6 | Jul 7 | S | 10,250 | $43.60 | Sale −$446,900 | not reported | Yes | Form 4 |
| Fitzpatrick JenniferChief Legal Officer | Jul 6 | Jul 7 | M · derivative | 10,250 | $6.11 | $62,628 | 40,685 | Yes | Form 4 |
| Orbimed Advisors LLC | Jun 30 | Jul 2 | S | 115,844 | $45.50 | Sale −$5,270,902 | 2,555,877 | Yes | Form 4 |
| Thompson Peter A. | Jun 30 | Jul 2 | S | 115,844 | $45.50 | Sale −$5,270,902 | 2,555,877 | Yes | Form 4 |
| RA Capital Nexus Fund III, L.P. | Jun 17 | Jun 18 | A · derivative | 17,340 | $36.73 | $636,898 | 17,340 | No | Form 4 |
| Thompson Peter A. | Jun 17 | Jun 18 | A · derivative | 17,340 | $36.73 | $636,898 | 17,340 | No | Form 4 |
| Clancy Paul J | Jun 17 | Jun 18 | A · derivative | 17,340 | $36.73 | $636,898 | 17,340 | No | Form 4 |
| Booth Bruce | Jun 17 | Jun 18 | A · derivative | 17,340 | $36.73 | $636,898 | 17,340 | No | Form 4 |
| Stelzer Laurie | Jun 17 | Jun 18 | A · derivative | 17,340 | $36.73 | $636,898 | 17,340 | No | Form 4 |
| Resnick Joshua | Jun 17 | Jun 18 | A · derivative | 17,340 | $36.73 | $636,898 | 17,340 | No | Form 4 |
| Viney Joanne L. | Jun 17 | Jun 18 | A · derivative | 17,340 | $36.73 | $636,898 | 17,340 | No | Form 4 |
| Fleming Harold Edward | Jun 17 | Jun 18 | A · derivative | 17,340 | $36.73 | $636,898 | 17,340 | No | Form 4 |
| Ruddy Marcella K. | Jun 17 | Jun 18 | A · derivative | 17,340 | $36.73 | $636,898 | 17,340 | No | Form 4 |
| Orbimed Advisors LLC | May 27 | May 29 | S | 101 | $44.49 | Sale −$4,493 | 2,671,721 | Yes | Form 4 |
| Thompson Peter A. | May 27 | May 29 | S | 101 | $44.49 | Sale −$4,493 | 2,671,721 | Yes | Form 4 |
| Orbimed Advisors LLC | May 11 | May 11 | S | 184,639 | $46.22 | Sale −$8,534,015 | 2,671,822 | Yes | Form 4 |
| Thompson Peter A. | May 11 | May 11 | S | 184,639 | $46.22 | Sale −$8,534,015 | 2,671,822 | Yes | Form 4 |
| Orbimed Advisors LLC | May 8 | May 11 | S | 59,767 | $44.58 | Sale −$2,664,413 | 2,856,461 | Yes | Form 4 |
| Thompson Peter A. | May 8 | May 11 | S | 59,767 | $44.58 | Sale −$2,664,413 | 2,856,461 | Yes | Form 4 |
| Orbimed Advisors LLC | May 7 | May 11 | S | 48,546 | $44.61 | Sale −$2,165,637 | 2,916,228 | Yes | Form 4 |
| Thompson Peter A. | May 7 | May 11 | S | 48,546 | $44.61 | Sale −$2,165,637 | 2,916,228 | Yes | Form 4 |
| Orbimed Advisors LLC | Apr 18 | Apr 21 | S | 2,948 | $44.52 | Sale −$131,245 | 2,964,774 | Yes | Form 4 |
| Thompson Peter A. | Apr 18 | Apr 21 | S | 2,948 | $44.52 | Sale −$131,245 | 2,964,774 | Yes | Form 4 |
| Orbimed Advisors LLC | Apr 17 | Apr 21 | S | 52,397 | $44.68 | Sale −$2,341,098 | 2,967,722 | Yes | Form 4 |
| Thompson Peter A. | Apr 17 | Apr 21 | S | 52,397 | $44.68 | Sale −$2,341,098 | 2,967,722 | Yes | Form 4 |
| Orbimed Advisors LLC | Apr 16 | Apr 16 | S | 226,906 | $45.34 | Sale −$10,287,918 | 3,020,119 | Yes | Form 4 |
| Thompson Peter A. | Apr 16 | Apr 16 | S | 226,906 | $45.34 | Sale −$10,287,918 | 3,020,119 | Yes | Form 4 |
| Orbimed Advisors LLC | Apr 15 | Apr 16 | S | 235,863 | $44.64 | Sale −$10,528,924 | 3,247,025 | Yes | Form 4 |
| Thompson Peter A. | Apr 15 | Apr 16 | S | 235,863 | $44.64 | Sale −$10,528,924 | 3,247,025 | Yes | Form 4 |
| Orbimed Advisors LLC | Apr 14 | Apr 16 | S | 47,814 | $44.51 | Sale −$2,128,201 | 3,482,888 | Yes | Form 4 |
| Thompson Peter A. | Apr 14 | Apr 16 | S | 47,814 | $44.51 | Sale −$2,128,201 | 3,482,888 | Yes | Form 4 |
| Fitzpatrick JenniferChief Legal Officer | Mar 5 | Mar 6 | M | 10,250 | $6.11 | $62,628 | 10,250 | Yes | Form 4 |
| Fitzpatrick JenniferChief Legal Officer | Mar 5 | Mar 6 | S | 10,250 | $33.86 | Sale −$347,065 | not reported | Yes | Form 4 |
| Fitzpatrick JenniferChief Legal Officer | Mar 5 | Mar 6 | M · derivative | 10,250 | $6.11 | $62,628 | 50,935 | Yes | Form 4 |
| OrbiMed Capital GP VIII LLC | Feb 3 | Feb 4 | S | 29,063 | $44.58 | Sale −$1,295,629 | 3,530,702 | Yes | Form 4 |
| Thompson Peter A. | Feb 3 | Feb 4 | S | 29,063 | $44.58 | Sale −$1,295,629 | 3,530,702 | Yes | Form 4 |
| OrbiMed Capital GP VIII LLC | Feb 2 | Feb 4 | S | 1,890 | $44.57 | Sale −$84,237 | 3,559,765 | Yes | Form 4 |
| Thompson Peter A. | Feb 2 | Feb 4 | S | 1,890 | $44.57 | Sale −$84,237 | 3,559,765 | Yes | Form 4 |
| Winkelried Jon | Jan 22 | Jan 26 | S | 250,000 | $40.00 | Sale −$10,000,000 | 6,494,962 | No | Form 4 |
| Cloonan MichaelPresident & CEO | Jan 2 | Jan 6 | A · derivative | 436,100 | $39.21 | $17,099,481 | 436,100 | No | Form 4 |
| Ridloff ElenaCFO | Jan 2 | Jan 6 | A · derivative | 165,440 | $39.21 | $6,486,902 | 165,440 | No | Form 4 |
| McKee CharlotteChief Medical Officer | Jan 2 | Jan 6 | A · derivative | 155,700 | $39.21 | $6,104,997 | 155,700 | No | Form 4 |
| Fitzpatrick JenniferChief Legal Officer | Jan 2 | Jan 6 | A · derivative | 103,140 | $39.21 | $4,044,119 | 103,140 | No | Form 4 |
| Beer Caroline StarkChief Business Officer | Jan 2 | Jan 6 | A · derivative | 139,340 | $39.21 | $5,463,521 | 139,340 | No | Form 4 |
| Thompson Peter A. | Dec 24, 2025 | Dec 29, 2025 | S | 33,356 | $44.55 | Sale −$1,486,010 | 3,561,655 | Yes | Form 4 |
| OrbiMed Capital GP VIII LLC | Dec 24, 2025 | Dec 29, 2025 | S | 33,356 | $44.55 | Sale −$1,486,010 | 3,561,655 | Yes | Form 4 |
| Thompson Peter A. | Dec 19, 2025 | Dec 19, 2025 | S | 875 | $44.49 | Sale −$38,929 | 3,595,011 | Yes | Form 4 |
| OrbiMed Capital GP VIII LLC | Dec 19, 2025 | Dec 19, 2025 | S | 875 | $44.49 | Sale −$38,929 | 3,595,011 | Yes | Form 4 |
| Thompson Peter A. | Dec 18, 2025 | Dec 19, 2025 | S | 100 | $44.49 | Sale −$4,449 | 3,595,886 | Yes | Form 4 |
| OrbiMed Capital GP VIII LLC | Dec 18, 2025 | Dec 19, 2025 | S | 100 | $44.49 | Sale −$4,449 | 3,595,886 | Yes | Form 4 |
| Thompson Peter A. | Dec 17, 2025 | Dec 19, 2025 | S | 900 | $44.50 | Sale −$40,050 | 3,595,986 | Yes | Form 4 |
| OrbiMed Capital GP VIII LLC | Dec 17, 2025 | Dec 19, 2025 | S | 900 | $44.50 | Sale −$40,050 | 3,595,986 | Yes | Form 4 |
| Fitzpatrick JenniferChief Legal Officer | Dec 5, 2025 | Dec 9, 2025 | M | 10,250 | $6.11 | $62,628 | 10,250 | Yes | Form 4 |
| Fitzpatrick JenniferChief Legal Officer | Dec 5, 2025 | Dec 9, 2025 | S | 10,250 | $40.52 | Sale −$415,330 | not reported | Yes | Form 4 |
| Fitzpatrick JenniferChief Legal Officer | Dec 5, 2025 | Dec 9, 2025 | M · derivative | 10,250 | $6.11 | $62,628 | 61,185 | Yes | Form 4 |
| Thompson Peter A. | Nov 26, 2025 | Nov 26, 2025 | S | 1,600 | $44.49 | Sale −$71,184 | 3,596,886 | Yes | Form 4 |
| Orbimed Advisors LLC | Nov 26, 2025 | Nov 26, 2025 | S | 1,600 | $44.49 | Sale −$71,184 | 3,596,886 | Yes | Form 4 |
| Thompson Peter A. | Nov 25, 2025 | Nov 26, 2025 | S | 11,890 | $44.60 | Sale −$530,294 | 3,598,486 | Yes | Form 4 |
| Orbimed Advisors LLC | Nov 25, 2025 | Nov 26, 2025 | S | 11,890 | $44.60 | Sale −$530,294 | 3,598,486 | Yes | Form 4 |
| Thompson Peter A. | Nov 24, 2025 | Nov 26, 2025 | S | 94,583 | $44.54 | Sale −$4,212,727 | 3,610,376 | Yes | Form 4 |
| Orbimed Advisors LLC | Nov 24, 2025 | Nov 26, 2025 | S | 94,583 | $44.54 | Sale −$4,212,727 | 3,610,376 | Yes | Form 4 |
| Kolchinsky Peter | Nov 21, 2025 | Nov 24, 2025 | S | 1,210 | $39.50 | Sale −$47,795 | 6,897,623 | No | Form 4 |
| Kolchinsky Peter | Nov 21, 2025 | Nov 24, 2025 | S | 9,924 | $39.50 | Sale −$391,998 | 650,307 | No | Form 4 |
| Kolchinsky Peter | Nov 21, 2025 | Nov 24, 2025 | S | 6,440 | $39.50 | Sale −$254,380 | 2,198,082 | No | Form 4 |
| Kolchinsky Peter | Nov 21, 2025 | Nov 24, 2025 | S | 7,609 | $39.50 | Sale −$300,556 | 159,033 | No | Form 4 |
| Kolchinsky Peter | Nov 20, 2025 | Nov 24, 2025 | S | 150 | $39.89 | Sale −$5,984 | 6,898,929 | No | Form 4 |
| Kolchinsky Peter | Nov 20, 2025 | Nov 24, 2025 | S | 1,235 | $39.89 | Sale −$49,264 | 661,019 | No | Form 4 |
| Kolchinsky Peter | Nov 20, 2025 | Nov 24, 2025 | S | 801 | $39.89 | Sale −$31,952 | 2,205,034 | No | Form 4 |
| Kolchinsky Peter | Nov 20, 2025 | Nov 24, 2025 | S | 947 | $39.89 | Sale −$37,776 | 167,246 | No | Form 4 |
| Kolchinsky Peter | Nov 20, 2025 | Nov 24, 2025 | S | 96 | $40.50 | Sale −$3,888 | 6,898,833 | No | Form 4 |
| Kolchinsky Peter | Nov 20, 2025 | Nov 24, 2025 | S | 788 | $40.50 | Sale −$31,914 | 660,231 | No | Form 4 |
| Kolchinsky Peter | Nov 20, 2025 | Nov 24, 2025 | S | 512 | $40.50 | Sale −$20,736 | 2,204,522 | No | Form 4 |
| Kolchinsky Peter | Nov 20, 2025 | Nov 24, 2025 | S | 604 | $40.50 | Sale −$24,462 | 166,642 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 19, 2025 | Nov 19, 2025 | S | 2,276 | $40.01 | Sale −$91,063 | 6,899,081 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 19, 2025 | Nov 19, 2025 | S | 18,684 | $40.01 | Sale −$747,547 | 662,266 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 19, 2025 | Nov 19, 2025 | S | 12,126 | $40.01 | Sale −$485,161 | 2,205,843 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 19, 2025 | Nov 19, 2025 | S | 14,325 | $40.01 | Sale −$573,143 | 168,202 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 19, 2025 | Nov 19, 2025 | S | 2 | $40.61 | Sale −$81 | 6,899,079 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 19, 2025 | Nov 19, 2025 | S | 12 | $40.61 | Sale −$487 | 662,254 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 19, 2025 | Nov 19, 2025 | S | 8 | $40.61 | Sale −$325 | 2,205,835 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 19, 2025 | Nov 19, 2025 | S | 9 | $40.61 | Sale −$365 | 168,193 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 18, 2025 | Nov 19, 2025 | S | 332 | $39.57 | Sale −$13,137 | 6,901,357 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 18, 2025 | Nov 19, 2025 | S | 2,728 | $39.57 | Sale −$107,947 | 680,950 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 18, 2025 | Nov 19, 2025 | S | 1,770 | $39.57 | Sale −$70,039 | 2,217,969 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 18, 2025 | Nov 19, 2025 | S | 2,092 | $39.57 | Sale −$82,780 | 182,527 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 17, 2025 | Nov 19, 2025 | S | 2,182 | $40.20 | Sale −$87,716 | 6,903,443 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 17, 2025 | Nov 19, 2025 | S | 17,913 | $40.20 | Sale −$720,103 | 698,075 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 17, 2025 | Nov 19, 2025 | S | 11,626 | $40.20 | Sale −$467,365 | 2,229,082 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 17, 2025 | Nov 19, 2025 | S | 13,734 | $40.20 | Sale −$552,107 | 195,657 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 17, 2025 | Nov 19, 2025 | S | 1,701 | $41.05 | Sale −$69,826 | 6,901,742 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 17, 2025 | Nov 19, 2025 | S | 13,964 | $41.05 | Sale −$573,222 | 684,111 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 17, 2025 | Nov 19, 2025 | S | 9,063 | $41.05 | Sale −$372,036 | 2,220,019 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 17, 2025 | Nov 19, 2025 | S | 10,707 | $41.05 | Sale −$439,522 | 184,950 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 17, 2025 | Nov 19, 2025 | S | 53 | $42.10 | Sale −$2,231 | 6,901,689 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 17, 2025 | Nov 19, 2025 | S | 433 | $42.10 | Sale −$18,229 | 683,678 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 17, 2025 | Nov 19, 2025 | S | 280 | $42.10 | Sale −$11,788 | 2,219,739 | No | Form 4 |
| Ra Capital Management, L.P. | Nov 17, 2025 | Nov 19, 2025 | S | 331 | $42.10 | Sale −$13,935 | 184,619 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Oct 28, 2025 | Oct 28, 2025 | S | 3,624 | $39.58 | Sale −$143,438 | 6,905,625 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Oct 28, 2025 | Oct 28, 2025 | S | 31,392 | $39.58 | Sale −$1,242,495 | 715,988 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Oct 28, 2025 | Oct 28, 2025 | S | 17,118 | $39.58 | Sale −$677,530 | 2,240,708 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Oct 28, 2025 | Oct 28, 2025 | S | 10,476 | $39.58 | Sale −$414,640 | 209,391 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Oct 24, 2025 | Oct 28, 2025 | S | 14,116 | $39.50 | Sale −$557,582 | 6,909,249 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Oct 24, 2025 | Oct 28, 2025 | S | 122,271 | $39.50 | Sale −$4,829,705 | 747,380 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Oct 24, 2025 | Oct 28, 2025 | S | 66,672 | $39.50 | Sale −$2,633,544 | 2,257,826 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Oct 24, 2025 | Oct 28, 2025 | S | 107,941 | $39.50 | Sale −$4,263,670 | 219,867 | No | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 21, 2025 | Oct 22, 2025 | M | 13,324 | $6.11 | $81,410 | 560,667 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 21, 2025 | Oct 22, 2025 | S | 13,324 | $34.44 | Sale −$458,879 | 547,343 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 21, 2025 | Oct 22, 2025 | M | 30,049 | $6.11 | $183,599 | 577,392 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 21, 2025 | Oct 22, 2025 | S | 30,049 | $35.63 | Sale −$1,070,646 | 547,343 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 21, 2025 | Oct 22, 2025 | M | 22,895 | $6.11 | $139,888 | 570,238 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 21, 2025 | Oct 22, 2025 | S | 22,895 | $36.60 | Sale −$837,957 | 547,343 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 21, 2025 | Oct 22, 2025 | M | 33,532 | $6.11 | $204,881 | 580,875 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 21, 2025 | Oct 22, 2025 | S | 33,532 | $37.31 | Sale −$1,251,079 | 547,343 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 21, 2025 | Oct 22, 2025 | M · derivative | 13,324 | $6.11 | $81,410 | 139,618 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 21, 2025 | Oct 22, 2025 | M · derivative | 30,049 | $6.11 | $183,599 | 109,569 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 21, 2025 | Oct 22, 2025 | M · derivative | 22,895 | $6.11 | $139,888 | 86,674 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 21, 2025 | Oct 22, 2025 | M · derivative | 33,532 | $6.11 | $204,881 | 53,142 | Yes | Form 4 |
| Booth Bruce | Oct 21, 2025 | Oct 21, 2025 | S | 22,339 | $32.69 | Sale −$730,262 | 2,360,156 | Yes | Form 4 |
| Booth Bruce | Oct 21, 2025 | Oct 21, 2025 | S | 4,688 | $32.69 | Sale −$153,251 | 697,297 | Yes | Form 4 |
| Booth Bruce | Oct 21, 2025 | Oct 21, 2025 | S | 19,948 | $33.87 | Sale −$675,639 | 2,340,208 | Yes | Form 4 |
| Booth Bruce | Oct 21, 2025 | Oct 21, 2025 | S | 4,187 | $33.87 | Sale −$141,814 | 693,110 | Yes | Form 4 |
| Booth Bruce | Oct 21, 2025 | Oct 21, 2025 | S | 5,763 | $34.91 | Sale −$201,186 | 2,334,445 | Yes | Form 4 |
| Booth Bruce | Oct 21, 2025 | Oct 21, 2025 | S | 1,210 | $34.91 | Sale −$42,241 | 691,900 | Yes | Form 4 |
| Booth Bruce | Oct 21, 2025 | Oct 21, 2025 | S | 25,327 | $35.69 | Sale −$903,921 | 2,309,118 | Yes | Form 4 |
| Booth Bruce | Oct 21, 2025 | Oct 21, 2025 | S | 5,316 | $35.69 | Sale −$189,728 | 686,584 | Yes | Form 4 |
| Booth Bruce | Oct 21, 2025 | Oct 21, 2025 | S | 83 | $36.42 | Sale −$3,023 | 2,309,035 | Yes | Form 4 |
| Booth Bruce | Oct 21, 2025 | Oct 21, 2025 | S | 17 | $36.42 | Sale −$619 | 686,567 | Yes | Form 4 |
| Booth Bruce | Oct 20, 2025 | Oct 20, 2025 | S | 20,485 | $31.79 | Sale −$651,218 | 2,408,283 | Yes | Form 4 |
| Booth Bruce | Oct 20, 2025 | Oct 20, 2025 | S | 4,300 | $31.79 | Sale −$136,697 | 707,397 | Yes | Form 4 |
| Booth Bruce | Oct 20, 2025 | Oct 20, 2025 | S | 25,788 | $32.33 | Sale −$833,726 | 2,382,495 | Yes | Form 4 |
| Booth Bruce | Oct 20, 2025 | Oct 20, 2025 | S | 5,412 | $32.33 | Sale −$174,970 | 701,985 | Yes | Form 4 |
| Booth Bruce | Oct 17, 2025 | Oct 20, 2025 | S | 28,821 | $32.10 | Sale −$925,154 | 2,450,467 | Yes | Form 4 |
| Booth Bruce | Oct 17, 2025 | Oct 20, 2025 | S | 6,049 | $32.10 | Sale −$194,173 | 716,252 | Yes | Form 4 |
| Booth Bruce | Oct 17, 2025 | Oct 20, 2025 | S | 21,451 | $32.71 | Sale −$701,662 | 2,429,016 | Yes | Form 4 |
| Booth Bruce | Oct 17, 2025 | Oct 20, 2025 | S | 4,503 | $32.71 | Sale −$147,293 | 711,749 | Yes | Form 4 |
| Booth Bruce | Oct 17, 2025 | Oct 20, 2025 | S | 248 | $33.47 | Sale −$8,301 | 2,428,768 | Yes | Form 4 |
| Booth Bruce | Oct 17, 2025 | Oct 20, 2025 | S | 52 | $33.47 | Sale −$1,740 | 711,697 | Yes | Form 4 |
| Booth Bruce | Oct 16, 2025 | Oct 20, 2025 | S | 8,596 | $30.15 | Sale −$259,169 | 2,610,589 | Yes | Form 4 |
| Booth Bruce | Oct 16, 2025 | Oct 20, 2025 | S | 1,804 | $30.15 | Sale −$54,391 | 749,860 | Yes | Form 4 |
| Booth Bruce | Oct 16, 2025 | Oct 20, 2025 | S | 45,117 | $31.69 | Sale −$1,429,758 | 2,565,472 | Yes | Form 4 |
| Booth Bruce | Oct 16, 2025 | Oct 20, 2025 | S | 9,470 | $31.69 | Sale −$300,104 | 740,390 | Yes | Form 4 |
| Booth Bruce | Oct 16, 2025 | Oct 20, 2025 | S | 73,296 | $32.84 | Sale −$2,407,041 | 2,492,176 | Yes | Form 4 |
| Booth Bruce | Oct 16, 2025 | Oct 20, 2025 | S | 15,384 | $32.84 | Sale −$505,211 | 725,006 | Yes | Form 4 |
| Booth Bruce | Oct 16, 2025 | Oct 20, 2025 | S | 12,888 | $33.38 | Sale −$430,201 | 2,479,288 | Yes | Form 4 |
| Booth Bruce | Oct 16, 2025 | Oct 20, 2025 | S | 2,705 | $33.38 | Sale −$90,293 | 722,301 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 16, 2025 | Oct 17, 2025 | M | 10,225 | $6.11 | $62,475 | 557,568 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 16, 2025 | Oct 17, 2025 | S | 10,225 | $31.46 | Sale −$321,679 | 547,343 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 16, 2025 | Oct 17, 2025 | M | 200 | $6.11 | $1,222 | 547,543 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 16, 2025 | Oct 17, 2025 | S | 200 | $34.00 | Sale −$6,800 | 547,343 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 16, 2025 | Oct 17, 2025 | M · derivative | 10,225 | $6.11 | $62,475 | 153,142 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 16, 2025 | Oct 17, 2025 | M · derivative | 200 | $6.11 | $1,222 | 152,942 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 15, 2025 | Oct 17, 2025 | M | 14,775 | $6.11 | $90,275 | 562,118 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 15, 2025 | Oct 17, 2025 | S | 14,775 | $31.11 | Sale −$459,650 | 547,343 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Oct 15, 2025 | Oct 17, 2025 | M · derivative | 14,775 | $6.11 | $90,275 | 163,367 | Yes | Form 4 |
| Booth Bruce | Oct 15, 2025 | Oct 15, 2025 | S | 65,726 | $30.37 | Sale −$1,996,099 | 2,649,217 | Yes | Form 4 |
| Booth Bruce | Oct 15, 2025 | Oct 15, 2025 | S | 13,795 | $30.37 | Sale −$418,954 | 757,967 | Yes | Form 4 |
| Booth Bruce | Oct 15, 2025 | Oct 15, 2025 | S | 30,032 | $31.12 | Sale −$934,596 | 2,619,185 | Yes | Form 4 |
| Booth Bruce | Oct 15, 2025 | Oct 15, 2025 | S | 6,303 | $31.12 | Sale −$196,149 | 751,664 | Yes | Form 4 |
| Booth Bruce | Oct 14, 2025 | Oct 15, 2025 | S | 501 | $29.95 | Sale −$15,005 | 2,714,943 | Yes | Form 4 |
| Booth Bruce | Oct 14, 2025 | Oct 15, 2025 | S | 105 | $29.95 | Sale −$3,145 | 771,762 | Yes | Form 4 |
| Booth Bruce | Oct 13, 2025 | Oct 15, 2025 | S | 44,048 | $30.32 | Sale −$1,335,535 | 2,719,526 | Yes | Form 4 |
| Booth Bruce | Oct 13, 2025 | Oct 15, 2025 | S | 9,245 | $30.32 | Sale −$280,308 | 772,724 | Yes | Form 4 |
| Booth Bruce | Oct 13, 2025 | Oct 15, 2025 | S | 4,082 | $31.03 | Sale −$126,664 | 2,715,444 | Yes | Form 4 |
| Booth Bruce | Oct 13, 2025 | Oct 15, 2025 | S | 857 | $31.03 | Sale −$26,593 | 771,867 | Yes | Form 4 |
| Booth Bruce | Oct 10, 2025 | Oct 15, 2025 | S | 16,727 | $29.98 | Sale −$501,475 | 2,763,574 | Yes | Form 4 |
| Booth Bruce | Oct 10, 2025 | Oct 15, 2025 | S | 3,511 | $29.98 | Sale −$105,260 | 781,969 | Yes | Form 4 |
| Booth Bruce | Oct 6, 2025 | Oct 7, 2025 | S | 9,753 | $29.95 | Sale −$292,102 | 2,780,301 | Yes | Form 4 |
| Booth Bruce | Oct 6, 2025 | Oct 7, 2025 | S | 2,047 | $29.95 | Sale −$61,308 | 785,480 | Yes | Form 4 |
| Booth Bruce | Oct 3, 2025 | Oct 7, 2025 | S | 31,198 | $30.00 | Sale −$935,940 | 2,790,054 | Yes | Form 4 |
| Booth Bruce | Oct 3, 2025 | Oct 7, 2025 | S | 6,548 | $30.00 | Sale −$196,440 | 787,527 | Yes | Form 4 |
| Beer Caroline StarkChief Business Officer | Oct 1, 2025 | Oct 3, 2025 | A · derivative | 255,000 | $28.47 | $7,259,850 | 255,000 | No | Form 4 |
| Booth Bruce | Oct 1, 2025 | Oct 1, 2025 | S | 165 | $29.95 | Sale −$4,942 | 2,821,252 | Yes | Form 4 |
| Booth Bruce | Oct 1, 2025 | Oct 1, 2025 | S | 35 | $29.95 | Sale −$1,048 | 794,075 | Yes | Form 4 |
| Booth Bruce | Sep 30, 2025 | Oct 1, 2025 | S | 10,239 | $30.06 | Sale −$307,784 | 2,821,417 | Yes | Form 4 |
| Booth Bruce | Sep 30, 2025 | Oct 1, 2025 | S | 2,149 | $30.06 | Sale −$64,599 | 794,110 | Yes | Form 4 |
| Booth Bruce | Sep 29, 2025 | Oct 1, 2025 | S | 54,637 | $30.09 | Sale −$1,644,027 | 2,831,656 | Yes | Form 4 |
| Booth Bruce | Sep 29, 2025 | Oct 1, 2025 | S | 11,468 | $30.09 | Sale −$345,072 | 796,259 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Sep 29, 2025 | Sep 30, 2025 | M | 7,793 | $6.11 | $47,615 | 555,136 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Sep 29, 2025 | Sep 30, 2025 | S | 7,793 | $29.70 | Sale −$231,452 | 547,343 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Sep 29, 2025 | Sep 30, 2025 | M · derivative | 7,793 | $6.11 | $47,615 | 178,142 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Sep 26, 2025 | Sep 30, 2025 | M | 17,207 | $6.11 | $105,135 | 564,550 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Sep 26, 2025 | Sep 30, 2025 | S | 17,207 | $28.85 | Sale −$496,422 | 547,343 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Sep 26, 2025 | Sep 30, 2025 | M · derivative | 17,207 | $6.11 | $105,135 | 185,935 | Yes | Form 4 |
| Fitzpatrick JenniferChief Legal Officer | Sep 4, 2025 | Sep 5, 2025 | M | 10,250 | $6.11 | $62,628 | 10,250 | Yes | Form 4 |
| Fitzpatrick JenniferChief Legal Officer | Sep 4, 2025 | Sep 5, 2025 | S | 10,250 | $23.12 | Sale −$236,980 | not reported | Yes | Form 4 |
| Fitzpatrick JenniferChief Legal Officer | Sep 4, 2025 | Sep 5, 2025 | M · derivative | 10,250 | $6.11 | $62,628 | 71,435 | Yes | Form 4 |
| Ridloff ElenaCFO & Head of Corp. Dev. | Sep 2, 2025 | Sep 3, 2025 | S | 8,836 | $25.08 | Sale −$221,607 | 38,532 | Yes | Form 4 |
| Ridloff ElenaCFO & Head of Corp. Dev. | Aug 29, 2025 | Sep 3, 2025 | S | 748 | $25.18 | Sale −$18,835 | 47,368 | Yes | Form 4 |
| Ridloff ElenaCFO & Head of Corp. Dev. | Aug 28, 2025 | Aug 28, 2025 | S | 16,098 | $25.97 | Sale −$418,065 | 48,116 | Yes | Form 4 |
| Ridloff ElenaCFO & Head of Corp. Dev. | Aug 27, 2025 | Aug 28, 2025 | S | 3,618 | $25.10 | Sale −$90,812 | 64,214 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Aug 27, 2025 | Aug 28, 2025 | M | 7,426 | $6.11 | $45,373 | 554,769 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Aug 27, 2025 | Aug 28, 2025 | S | 7,426 | $25.01 | Sale −$185,724 | 547,343 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Aug 27, 2025 | Aug 28, 2025 | M · derivative | 7,426 | $6.11 | $45,373 | 203,142 | Yes | Form 4 |
| Ridloff ElenaCFO & Head of Corp. Dev. | Aug 26, 2025 | Aug 28, 2025 | S | 3,700 | $25.13 | Sale −$92,981 | 67,832 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Aug 26, 2025 | Aug 28, 2025 | M | 17,574 | $6.11 | $107,377 | 564,917 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Aug 26, 2025 | Aug 28, 2025 | S | 17,574 | $24.96 | Sale −$438,647 | 547,343 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Aug 26, 2025 | Aug 28, 2025 | M · derivative | 17,574 | $6.11 | $107,377 | 210,568 | Yes | Form 4 |
| Ridloff ElenaCFO & Head of Corp. Dev. | Aug 20, 2025 | Aug 21, 2025 | S | 17,500 | $22.69 | Sale −$397,075 | 71,532 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Aug 20, 2025 | Aug 21, 2025 | M | 25,000 | $6.11 | $152,750 | 572,343 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Aug 20, 2025 | Aug 21, 2025 | S | 25,000 | $22.75 | Sale −$568,750 | 547,343 | Yes | Form 4 |
| Cloonan MichaelPresident & CEO | Aug 20, 2025 | Aug 21, 2025 | M · derivative | 25,000 | $6.11 | $152,750 | 228,142 | Yes | Form 4 |
| Ridloff ElenaCFO & Head of Corp. Dev. | Aug 19, 2025 | Aug 21, 2025 | S | 34,500 | $21.08 | Sale −$727,260 | 89,032 | Yes | Form 4 |
| Coulter James G | Jun 27, 2025 | Jul 1, 2025 | P | 60,000 | $15.84 | Purchase +$950,400 | 6,744,962 | No | Form 4 |
| Kolchinsky Peter | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 19,959 | $16.99 | $339,103 | 19,959 | No | Form 4 |
| Booth Bruce | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 19,959 | $16.99 | $339,103 | 19,959 | No | Form 4 |
| Clancy Paul J | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 19,959 | $16.99 | $339,103 | 19,959 | No | Form 4 |
| Fleming Harold Edward | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 19,959 | $16.99 | $339,103 | 19,959 | No | Form 4 |
| Resnick Joshua | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 19,959 | $16.99 | $339,103 | 19,959 | No | Form 4 |
| Ruddy Marcella K. | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 19,959 | $16.99 | $339,103 | 19,959 | No | Form 4 |
| Stelzer Laurie | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 19,959 | $16.99 | $339,103 | 19,959 | No | Form 4 |
| Thompson Peter A. | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 19,959 | $16.99 | $339,103 | 19,959 | No | Form 4 |
| Viney Joanne L. | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 19,959 | $16.99 | $339,103 | 19,959 | No | Form 4 |
| Tpg Gp A, LLC | Feb 10, 2025 | Feb 12, 2025 | C | 4,875,547 | not reported | not reported | 5,559,962 | No | Form 4 |
| Tpg Gp A, LLC | Feb 10, 2025 | Feb 12, 2025 | P | 1,125,000 | $18.00 | Purchase +$20,250,000 | 6,684,962 | No | Form 4 |
| Tpg Gp A, LLC | Feb 10, 2025 | Feb 12, 2025 | C · derivative | 1,276,276 | not reported | not reported | not reported | No | Form 4 |
| Tpg Gp A, LLC | Feb 10, 2025 | Feb 12, 2025 | C · derivative | 1,806,318 | not reported | not reported | not reported | No | Form 4 |
| Tpg Gp A, LLC | Feb 10, 2025 | Feb 12, 2025 | C · derivative | 2,275,528 | not reported | not reported | not reported | No | Form 4 |
| Tpg Gp A, LLC | Feb 10, 2025 | Feb 12, 2025 | C · derivative | 1,765,541 | not reported | not reported | not reported | No | Form 4 |
| OrbiMed Capital GP VIII LLC | Feb 10, 2025 | Feb 10, 2025 | C | 3,154,959 | not reported | not reported | 3,154,959 | No | Form 4 |
| OrbiMed Capital GP VIII LLC | Feb 10, 2025 | Feb 10, 2025 | P | 550,000 | $18.00 | Purchase +$9,900,000 | 3,704,959 | No | Form 4 |
| OrbiMed Capital GP VIII LLC | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 2,560,951 | $0.00 | $0 | not reported | No | Form 4 |
| OrbiMed Capital GP VIII LLC | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 2,048,760 | $0.00 | $0 | not reported | No | Form 4 |
| Booth Bruce | Feb 10, 2025 | Feb 10, 2025 | C | 2,886,293 | not reported | not reported | 2,886,293 | No | Form 4 |
| Booth Bruce | Feb 10, 2025 | Feb 10, 2025 | C | 747,727 | not reported | not reported | 747,727 | No | Form 4 |
| Booth Bruce | Feb 10, 2025 | Feb 10, 2025 | P | 60,000 | $18.00 | Purchase +$1,080,000 | 807,727 | No | Form 4 |
| Booth Bruce | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 1,051,051 | $0.00 | $0 | not reported | No | Form 4 |
| Booth Bruce | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 1,806,317 | $0.00 | $0 | not reported | No | Form 4 |
| Booth Bruce | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 1,298,332 | $0.00 | $0 | not reported | No | Form 4 |
| Booth Bruce | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 61,463 | $0.00 | $0 | not reported | No | Form 4 |
| Booth Bruce | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 1,092,504 | $0.00 | $0 | not reported | No | Form 4 |
| Atlas Venture Fund XI, L.P. | Feb 10, 2025 | Feb 10, 2025 | C | 2,886,293 | not reported | not reported | 2,886,293 | No | Form 4 |
| Atlas Venture Fund XI, L.P. | Feb 10, 2025 | Feb 10, 2025 | C | 747,727 | not reported | not reported | 747,727 | No | Form 4 |
| Atlas Venture Fund XI, L.P. | Feb 10, 2025 | Feb 10, 2025 | P | 60,000 | $18.00 | Purchase +$1,080,000 | 807,727 | No | Form 4 |
| Atlas Venture Fund XI, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 1,051,051 | $0.00 | $0 | not reported | No | Form 4 |
| Atlas Venture Fund XI, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 1,806,317 | $0.00 | $0 | not reported | No | Form 4 |
| Atlas Venture Fund XI, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 1,298,332 | $0.00 | $0 | not reported | No | Form 4 |
| Atlas Venture Fund XI, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 61,463 | $0.00 | $0 | not reported | No | Form 4 |
| Atlas Venture Fund XI, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 1,092,504 | $0.00 | $0 | not reported | No | Form 4 |
| Thompson Peter A. | Feb 10, 2025 | Feb 10, 2025 | C | 3,154,959 | not reported | not reported | 3,154,959 | No | Form 4 |
| Thompson Peter A. | Feb 10, 2025 | Feb 10, 2025 | P | 550,000 | $18.00 | Purchase +$9,900,000 | 3,704,959 | No | Form 4 |
| Thompson Peter A. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 2,560,951 | $0.00 | $0 | not reported | No | Form 4 |
| Thompson Peter A. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 2,048,760 | $0.00 | $0 | not reported | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C | 5,021,990 | not reported | not reported | 5,900,779 | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C | 527,444 | not reported | not reported | 869,651 | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C | 2,222,084 | not reported | not reported | 2,222,084 | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C | 179,975 | not reported | not reported | 327,808 | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | P | 1,022,586 | $18.00 | Purchase +$18,406,548 | 6,923,365 | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | P | 102,414 | $18.00 | Purchase +$1,843,452 | 2,324,498 | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 819,153 | $0.00 | $0 | not reported | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 319,069 | $0.00 | $0 | not reported | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 138,054 | $0.00 | $0 | not reported | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 1,229,830 | $0.00 | $0 | not reported | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 451,580 | $0.00 | $0 | not reported | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 124,908 | $0.00 | $0 | not reported | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 923,773 | $0.00 | $0 | not reported | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 2,155,469 | $0.00 | $0 | not reported | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 4,364,874 | $0.00 | $0 | not reported | No | Form 4 |
| Ra Capital Management, L.P. | Feb 10, 2025 | Feb 10, 2025 | C · derivative | 1,091,219 | $0.00 | $0 | not reported | No | Form 4 |
| McKee CharlotteChief Medical Officer | Feb 6, 2025 | Feb 10, 2025 | A · derivative | 148,536 | $18.00 | $2,673,648 | 148,536 | No | Form 4 |
| Ridloff ElenaCFO & Head of Corp. Dev. | Feb 6, 2025 | Feb 10, 2025 | A · derivative | 157,820 | $18.00 | $2,840,760 | 157,820 | No | Form 4 |
| Cloonan MichaelPresident & CEO | Feb 6, 2025 | Feb 10, 2025 | A · derivative | 450,252 | $18.00 | $8,104,536 | 450,252 | No | Form 4 |
| Viney Joanne L. | Feb 6, 2025 | Feb 10, 2025 | A · derivative | 39,919 | $18.00 | $718,542 | 39,919 | No | Form 4 |
| Ruddy Marcella K. | Feb 6, 2025 | Feb 10, 2025 | A · derivative | 39,919 | $18.00 | $718,542 | 39,919 | No | Form 4 |